Meeting
2018 Genitourinary Cancers Symposium
The role of the blood platelet-lymphocyte ratio, neutrophil–lymphocyte ratio and platelets in prognosis of metastatic renal cell carcinoma (mRCC).
Authors
Joanna Huszno
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland
Joanna Huszno , Zofia Kolosza
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 670)
DOI
10.1200/JCO.2018.36.6_suppl.670
Abstract #
670
Poster Bd #
J21
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Predictive value of C reactive protein (CRP) in patients with metastatic renal cell carcinoma (mRCC) treated with pembrolizumab (pembro) and axitinib (axi).
First Author: Aitzaz Qaisar
Poster
2022 ASCO Annual Meeting
The prognostic value of peripheral blood inflammatory indices early variation in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (Δ-Meet-URO analysis).
First Author: Sara Elena Rebuzzi
Poster
2020 Gastrointestinal Cancers Symposium
Association of neutrophil, platelet, and lymphocyte ratios with prognosis in metastatic pancreatic cancer.
First Author: Jessica Allen
Poster
2020 Gastrointestinal Cancers Symposium
Evaluation of the ratio of plasma fibrinogen to platelet in resectable pancreatic cancer.
First Author: Yusuke Arakawa